Skip to content

Evaluation of the anti-ageing efficacy of Hilow Haenkenium cream in healthy women

Evaluation of the anti-ageing efficacy of Hilow Haenkenium cream in healthy women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12067877
Enrollment
50
Registered
2019-06-04
Start date
2017-01-09
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild-to-moderate ageing skin signs and skin redness due to cold and wind Not Applicable

Interventions

Participants attended clinic visits at screening, baseline and after 14, 28, 56 and 84 days product use (Profhilo Haenkenium®). During the screening visit subjects were informed on study procedures, r
while skin strippings (trough the stratum corneum, superficial layer of the skin) were taken using minimally invasive adhesive foils. The total duration of each visit was 30 minutes. The total study d

Sponsors

IBSA Farmaceutici Italia S.r.l.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Healthy female subject 2. Caucasian ethnicity 3. Age between 40 and 65 years old 4. Subjects showing mild to moderate ageing skin signs and skin redness due to cold and wind 5. Subjects who have not been recently involved in any other similar study 6. Willingness to use during all the study period only the product to be tested 7. Willingness to not vary the normal daily routine

Exclusion criteria

Exclusion criteria: 1. Subject does not meet the inclusion criteria 2. Positive history for atopy or hypersensitive skin 3. Past history of allergy or sensitivity to cosmetics, toiletries, to solar and/or topical medications 4. Any skin condition that the principal investigator deems inappropriate for participation 5. Pregnancy or nursing women

Design outcomes

Primary

MeasureTime frame
Antiageing efficacy is measured by means of wrinkle depth and total skin antioxidant capacity using Ferric Reducing Antioxidant Power (FRAP) assay at baseline, and after 14, 28, 56 and 84 days of product use.

Secondary

MeasureTime frame
Skin redness and skin elasticity/compactness assessed using clinical assessment carried out by the dermatologist and the self-assessment carried out by the subjects participating in the study at baseline, and after 14, 28, 56 and 84 days of product use.

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026